Deciphera Pharmaceuticals, Inc.
DCPH
Revenue
45.00M
▼-3.30M▼-6.82%
3 Months ChangeAssets
420.93M
▼-52.64M▼-11.12%
3 Months ChangeLiabilities
104.88M
▼-17.77M▼-14.49%
3 Months ChangeFree Cash Flow
-54.73M
▼-4.92M▼-9.87%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-06-11
Form 8-K
ID: 0001193125-24-158772
2024-05-10
Form 10-Q
ID: 0001654151-24-000018
2024-04-29
Form 8-K
ID: 0001193125-24-119762
2024-02-06
Form 8-K
ID: 0001193125-24-024786
2024-01-08
Form 8-K
ID: 0001193125-24-003876
2023-10-30
Form 10-Q
ID: 0001654151-23-000019
2023-10-30
Form 8-K
ID: 0001193125-23-265657
2023-08-09
Form 10-Q
ID: 0001654151-23-000015
2023-08-09
Form 8-K
ID: 0001193125-23-206772
2023-08-03
Form 8-K
ID: 0001193125-23-202887